← The feed Many Minded · The brief
SUSTENANCE · forward · impact 2/5 · 2026-11-17 · Upside Foods

Upside Foods wins a second US clearance for a cheaper cultivated chicken

Upside says a new cultivated chicken, cleared by FDA and USDA, cuts production costs more than 10-fold and is priced near premium organic chicken.

Upside Foods has received US clearance for a second-generation cultivated chicken product. The FDA issued a 'no questions' letter in September, and USDA label approval followed in November. Upside says it is the first company cleared for two separate cultivated meat products.

The company says it scaled production 10,000-fold, using bioreactors with combined capacity above 20,000 litres, and can make over 1 million pounds (about 450,000 kg) of cultivated chicken a year on less than half an acre. CEO Uma Valeti says production costs fell more than 10-fold compared with the earlier method. The product is priced comparable to premium organic chicken; for reference, USDA AMS reported organic chicken breast as low as $6.56 per lb in September.

The product is a hybrid. Cultivated cells make up at least 10% of it and appear second on the label after water, though the exact share is withheld. It also contains soy protein isolate, pea fibre and olive oil, and comes diced, shredded or as a Chef's Cut. Upside's first product was 99% cultivated chicken; Good Meat's Singapore product has 3%. It is served at eight California restaurants and Stanford University, and a halal certification from Circle H International is described by both companies as a world first for a cultivated meat producer.

Why it matters: protein is among the costliest parts of a diet, and a cleared product priced near premium organic chicken is a step toward cultivated meat competing on price rather than novelty. Prices at that level are still well above basic chicken, though.

Watch next: whether the cost claims hold up independently, since scale, cost and commercial-scale figures come from Upside and Valeti. The planned 30 million lb Illinois plant is on hold, a $50M bid for a North Carolina plant was dropped, and Upside is starting a new fundraising round after raising over $600M. Its lawsuits against Florida, and against Texas jointly with Wildtype, over state bans have both been allowed to proceed.

Source: Green Queen